
0:32
Short excerpt from a YouTube video (single speaker) summarizing a 2019 trial comparing semaglutide to a similar, lower-dose GLP-1 drug. The speaker reports DEXA-scan body-composition results: participants lost about six pounds on average; absolute lean mass fell slightly but lean mass increased as a percentage of total body weight, while body fat percentage declined.










